Ion Channel Activity of ApoL1 and its Kidney Disease-Associated Variants.
The Channel Activity of ApoL1 and Progressive Chronic Kidney Disease.
The Ion Channel Activity of ApoL1 and Podocyte Injury.
Cost effectiveness of a decision aid to reduce knowledge barriers to pursuit of live
kidney donor transplantation.
Interventions to Increase Pancreas Utilization.
Effect of Nutrition Education on Dialysis Patient Phosphorus and iPTH Levels.
Regulation of Nephron Progenitor Cell Self-Renewal and Differentiation.
Regulation of Renal Progenitor Cell Fate in Normal Kidney Development and Townes-Brocks
Syndrome.
Identifying Genetic Causes of Congenital Renal Disease.
Evaluation of RGD Integrin Antagonists for Treatment of Kidney Fibrosis.
Contribution of APOL1 to Gestational Hypertension. Low Birth Weight and Prematurity.
Long Term Health Outcomes After Live Kidney Donation in African Americans.
UCLA (Waterman) Research Services Agreement.
Choosing Immune Suppression in Renal Transplantation by Efficacy and Morbidity.
An open-label, prospective randomized, multi-center, Phase II Comparative Trial of
Thymoglobulin versus Simulect for the prevention of delayed graft function and acute
allograft rejection in renal allograft recipients.
Liver transplantation: Patient-reported outcomes, healthcare cost and comparative
modeling of the simultaneous liver-kidney allocation policy.
Cost effectiveness of a decision aid to reduce knowledge barriers to pursuit of live
kidney donor transplantation
Modifiable factors affecting live donor disparities (MFALDD).
Economic Strategies to Reduce Organ Discard Through Risk-Adjusted Payment Mechanisms.
Central artery pressures and waveform analysis in gestational hypertension and preeclampsia.
Volume dependency of arterial stiffness.
A Randomized, Multi-Country, Multicenter, Double -Blind, Parallel, Placebo-controlled
Study of the Effects of Atrasentan on Renal outcomes in Subjects with
Type 2 Diabetes and Nephropathy (SONAR study site).
Pathophysiological mechanisms of Cardiorenal Syndrome (CRS) with an emphasis on novel
treatments targeting bidirectional signaling pathways.